ranibizumab

The drug is used to treat various eye diseases, including neovascular (exudative) age-related macular degeneration, diabetic macular edema, proliferative diabetic retinopathy, vision impairment due to retinal vein thrombosis, as well as choroidal neovascularization.

Form: solution for injection

ATC: S01LA04

Manufacturer: Pfizer Italia S.p.A. (manufacturing APIs; primary packaging; quality control at batch release for parameters "Endotoxins" and "Sterility")